Clinical trial · Research (general)← The news desk

✦ The Dispatch

USPIO enhanced MR imaging in CNS tumors (UMIC): a study protocol

A dispatch from PubMed — filed

Tumor-associated macrophages (TAMs) are key drivers of brain tumor progression and therapy resistance. Clinically applicable biomarkers capable of evaluating TAM populations in vivo are highly sought, with one potential imaging marker being ultrasmall superparamagnetic iron oxide nanoparticle (USPIO)-enhanced MRI....

Clinical Takeaway

No actionable change — this study protocol concerns brain tumor imaging and has no relevance to audiology practice.

Why It Matters

This article has no meaningful relevance to the audiology field and appears to have been indexed in error for this feed.

Key Points
  1. 01Study protocol describes USPIO-enhanced MRI to image tumor-associated macrophages in CNS tumors.
  2. 02Published in Nanomedicine; no audiology or hearing-health content.
  3. 03No connection to cochlear, vestibular, or hearing-related research.
  4. 04Inclusion in an audiology feed appears to be an indexing or aggregation error.
Research metadata
PMID
42267547
DOI
10.1080/17435889.2026.2681555.
Journal
Nanomedicine
Publication type
study_protocol
Evidence level
na
Population
Patients with CNS tumors
Intervention
USPIO-enhanced MRI imaging of tumor-associated macrophages

Primary outcomes

Visualization of tumor-associated macrophages in CNS tumors via USPIO-enhanced MRI

Related stories